Zomepirac Sodium

CAS No. 64092-48-4

Zomepirac Sodium ( —— )

Catalog No. M15437 CAS No. 64092-48-4

Zomepirac, formerly marketed as Zomax tablets, was associated with fatal and near-fatal anaphylactoid reactions.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 26 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Zomepirac Sodium
  • Note
    Research use only, not for human use.
  • Brief Description
    Zomepirac, formerly marketed as Zomax tablets, was associated with fatal and near-fatal anaphylactoid reactions.
  • Description
    Zomepirac, formerly marketed as Zomax tablets, was associated with fatal and near-fatal anaphylactoid reactions.
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    PDE2
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    64092-48-4
  • Formula Weight
    313.71
  • Molecular Formula
    C15H13ClNNaO3
  • Purity
    >98%(HPLC)
  • Solubility
    Water: 0.026 mg/mL
  • SMILES
    [Na+].CN1C(CC([O-])=O)=CC(C)=C1C(=O)C1=CC=C(Cl)C=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Hata AN, et al. Mol Pharmacol. 2005 Mar;67(3):640-7.
molnova catalog
related products
  • Chelerythrine

    Chelerythrine is a well-known protein kinase C inhibitor.

  • Difamilast

    Difamilast (OPA-15406) is a novel potent, selective phosphodiesterase IV (PDE4) inhibitor with preference for PDE4B (IC50=11.2 nM).

  • Tadalafil

    Tadalafil is a potent phosphodiesterase-5 (PDE5) inhibitor (IC50=1 nM).